LIPO Lipella Pharmaceuticals
- 3.110
- -0.070-2.20%
Lipella Pharmaceuticals News
Spartan Capital Securities, LLC Caps Off a Remarkable Year With Key December Transactions
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.'s $1.72 Million Private Placement
Lipella Pharmaceuticals Announces Publication In CUREUS On Non-Steroid Treatment Of Oral Lichen Planus Titled "Rationale For The Use Of Topical Calcineurin Inhibitors In The Management Of Oral Lichen Planus And Mucosal Inflammatory Diseases"
Express News | Lipella Pharmaceuticals Announces Publication in Cureus on Non-Steroid Treatment of Oral Lichen Planus
Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus
Lipella Pharmaceuticals Has Completed Dosing For The First Cohort In Its Phase 2A Trial Of LP-310, A Liposomal-tacrolimus Oral Rinse Being Developed For Oral Lichen Planus, Topline Data Is Expected By Year-end And Complete The Trial By Mid-2025
Express News | Lipella Pharmaceuticals Inc - Trial Expected to Conclude by Mid-2025 With Top-Line Data by Year-End 2024
Express News | Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group
Maxim Group Maintains Lipella Pharmaceuticals(LIPO.US) With Buy Rating
Maxim Group Keeps Their Buy Rating on Lipella Pharmaceuticals, Inc. (LIPO)
Express News | Lipella Pharmaceuticals Inc : Maxim Group Cuts Target Price to $10 From $16
Lipella Pharmaceuticals Third Quarter 2024 Earnings: US$1.29 Loss per Share (Vs US$1.84 Loss in 3Q 2023)
Lipella Pharmaceuticals Faces Nasdaq Delisting Risk Amid Compliance Challenges
Lipella Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Express News | Lipella Pharmaceuticals Will Be Issued U.S. Patent Number 12,138,345 Tomorrow Titled "DELIVERY OF AGENTS USING METASTABLE LIPOSOMES (FOR THE TREATMENT OF BLADDER CONDITIONS)"
Lipella Pharmaceuticals Inc Trading Halted, News Pending
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Lipella Pharmaceuticals To Carry Out 1-for-8 Reverse Stock Split On November 8th, 2024
Express News | Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split
Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference
No Data